| Primary Device ID | 10190302014298 |
| NIH Device Record Key | 57e34bbd-87ba-4fa1-ac0a-29a7a16b2ee8 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | CTS™ OpTmizer™ T-Cell Expansion Supplement |
| Version Model Number | A3747001 |
| Company DUNS | 118793157 |
| Company Name | LIFE TECHNOLOGIES CORPORATION |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 10190302014298 [Primary] |
| NDS | MEDIA, CULTURE, EX VIVO, TISSUE AND CELL |
| Steralize Prior To Use | false |
| Device Is Sterile | true |
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 5 |
| Public Version Date | 2019-11-18 |
| Device Publish Date | 2018-06-15 |
| 10190302005197 - Aim -V™ Medium | 2024-06-04 AIM V MED |
| 10190302012041 - Human CD99 FITC Conjugate | 2024-06-04 HU CD99 3B2/TA8 FITC MAB |
| 10190302012058 - Human CD99 R-PE Conjugate | 2024-06-04 HU CD99 3B2/TA8 PE MAB |
| 10190302012065 - Human CXCR4 (CD184) R-PE Conjugate | 2024-06-04 HU CXCR4 12G5 PE MAB |
| 10190302012164 - Anti-Human HLA-DR (Class II) FITC Conjugate | 2024-06-04 HU HLA-DR TU36 FITC MAB |
| 10190302012171 - Anti-Human HLA-DR (Class II) R-PE Conjugate | 2024-06-04 HU HLA-DR TU36 PE MAB |
| 10190302012188 - Anti-Human HLA-DR (Class II) APC Conjugate | 2024-06-04 HU HLA-DR TU36 APC MAB |
| 10190302012195 - Anti-Human HLA-DR (Class II) PE-Texas Red® Conjugate | 2024-06-04 HU HLA-DR TU36 PE-TX RED MAB |